Collection

Purinergic Signalling – Perspectives from Australia and New Zealand

Submission status
Closed

This issue aims to provide examples of purinergic research undertaken in Australia and New Zealand, spanning a range of purinergic molecules and pathways in different physiological and pathophysiological areas.

Reviews, original research articles, short communications and journal club articles will be considered for publication. All submissions must conform to the Submission Guidelines and be submitted via the manuscript submission portal. Subscription and open access options are available to authors. Enquiries can be sent to Ronald Sluyter (rsluyter@uow.edu.au).

Editors

  • Ronald Sluyter Ronald Sluyter , 

    Ronald Sluyter

    Ronald Sluyter is a professor in the School of Chemistry and Molecular Bioscience, University of Wollongong and group leader in the Illawarra Health and Medical Research Institute. His group largely explores the roles of P2X7 in health and disease. He is Co-President of the Australian and New Zealand Purine Club.

  • Jennie Cederholm Jennie Cederholm , 

    Jennie Cederholm

    Jennie Cederholm is a Senior Lecturer in the School of Medical Sciences (SoMS), UNSW Sydney. She is a member of the Sensori-Motor Physiology and Therapeutic Group in the Translational Neuroscience Facility, SoMS. Her research focuses on the molecular and cellular mechanisms of sensorineural hearing loss, in particular the role of P2X 2 receptors. She is Co-President of the Australian and New Zealand Purine Club.

  • Srdjan Vlajkovic Srdjan Vlajkovic , 

    Srdjan Vlajkovic

    Associate Professor Srdjan Vlajkovic is a co-director of the Auditory and Vestibular Neuroscience Cluster in the Department of Physiology at the University of Auckland. His research focus is on molecular mechanisms of sensorineural hearing loss and the development of inner ear therapeutics. His research has contributed to the current understanding of the role of adenosine receptors in the repair of cochlear injury and restoration of hearing.

  • Carolina Gubert Carolina Gubert  &

    Carolina Gubert

    The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia

  • Reece Sophocleous Reece Sophocleous

    Reece Sophocleous

    University of Wollongong, Wollongong, Australia

Articles (12 in this collection)

  6. The P2X1 receptor as a therapeutic target

    Authors (first, second and last of 4)

    • Felix M. Bennetts
    • Jesse I. Mobbs
    • David M. Thal
    • Content type: Review Article
    • Open Access
    • Published: 11 July 2022
    • Pages: 421 - 433